SCHEMBL4970533

SCHEMBL4970533

COc1cc(C(C=O)c2ccccc2)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
CNR2 P34972 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
KDM4E B2RXH2 1/20 0.36
GRM4 Q14833 1/20 0.36
UGCG Q16739 1/20 0.36
GRM2 Q14416 1/20 0.36
GRM3 Q14832 1/20 0.36
ERN1 O75460 1/20 0.35
NFE2L2 Q16236 1/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515708 0.88 LMNA (0.44) SMN1; SMN2TDP1L3MBTL1LMNAALDH1A1
SCHEMBL5877045 0.86 L3MBTL1 (0.53) TDP1L3MBTL1POLBALDH1A1MAPT
SCHEMBL1515750 0.86 L3MBTL1 (0.53) TDP1L3MBTL1POLBALDH1A1MAPT
SCHEMBL1515800 0.80 CES2 (0.42) SMN1; SMN2L3MBTL1LMNAMAPTKDM4E
SCHEMBL5898854 0.79 TUBB1 (0.49) SMN1; SMN2TDP1L3MBTL1LMNAALDH1A1
SCHEMBL3504212 0.76 GAA (0.38) SMN1; SMN2LMNAALDH1A1GRM2GRM3
SCHEMBL1515821 0.76 CYP3A4 (0.46) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL1515694 0.75 ACP3 (0.56) L3MBTL1LMNACNR2ALDH1A1MAPT
SCHEMBL1515778 0.74 CHRM2 (0.48) TDP1L3MBTL1
SCHEMBL4971811 0.74 SMN1; SMN2 (0.36) SMN1; SMN2TDP1L3MBTL1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed